AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
Stephen R. Wedge, Jane Kendrew, Laurent Hennequin, Paula J. Valentine, Simon T. Barry, Sandra R. Brave, Neil R. Smith, Neil H. James, Michael Dukes, Jon Curwen, Rosemary Chester, Janet A. Jackson, Sarah J. Boffey, Lyndsey L. Kilburn, Sharon Barnett, Graham H.P. Richmond, P.F. Wadsworth, Mike Walker, Alison Bigley, Sian Taylor, Lee Cooper, Sarah Beck, Juliane M. Jürgensmeier, Donald Ogilvie
Cancer Research, 2005
Abstract
This research paper explore the methodology and findings associated with Cancer Research. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).